#RegenMedAu July 2019

CCRM Australia | July 12, 2019 | Newsletter | No Comments

The July 2019 issue of the CCRM Australia newsletter, #RegenMedAu, is now available to read. Here are some of the highlights for CCRM Australia in July:

CCRM Au and BioCurate enter into an MoU to accelerate the translation of therapies in the Australian regenerative medicine sector
Centre for Commercialization of Regenerative Medicine Australia and The Medtech Actuator in partnership to accelerate the translation of medical devices in the Australian regenerative medicine sector
Cell therapies: How much will we pay?
CCRM Australia welcomes inaugural Global Network exchange student
Win-win mentoring nurtures next gen STEM leaders
Specialty stream partner (regenerative medicine) AusBiotech 2019 Conference
Industry News
Upcoming Events

Discover what other highlights have emerged and keep up to date with CCRM Australia in the latest edition of #RegenMedAu.

CCRM_au

@CCRM_au

We are excited to support @NSWStemCellNet with the Snapshot of Stem Cell and Regenerative Medicine Companies in Australia. The report provides an overview of the Australian #regenmed sector, featuring key companies based here. Read the report: nuvi.me/z775u8 pic.twitter.com/D9IB4y1bNT

3:00 am · October 28, 2021

CCRM_au

@CCRM_au

The #AusBio21 session on the public notification process for #regenerativemedicine therapies in Australia is starting soon. Don't miss out. pic.twitter.com/WLJdhGVtw7

1:25 am · October 28, 2021

CCRM_au

@CCRM_au

Join our #AusBio21 session at 12:30 pm AEDT today (28 Oct) for our sponsored session investigating regulatory approaches to regenerative medicine therapies in Australia. #regenerativemedicine #regulations pic.twitter.com/ZPv5v1DxDZ

10:00 pm · October 27, 2021

CCRM_au

@CCRM_au

Exciting development in the Australian Regenerative Medicine Sector with a strategic roadmap, an investment database and case studies to lead future growth. #regenmed #regenmedau twitter.com/AusBiotech/sta…

5:36 am · October 26, 2021

CCRM_au

@CCRM_au

Introducing John Martin as one of the initial Expert In Residence program members. John worked as CEO, chairman, director and adviser of ASX listed and emerging private technology and high growth businesses to offer #commercialisation advises in #regenmed product development. pic.twitter.com/JQNH2mJgjF

1:00 am · October 26, 2021

CCRM_au

@CCRM_au

We are seeking PC1 type or unclassified laboratory facility with a BSC II cabinet for a tissue engineering startup - preferably in Melbourne's northeast. Don't hesitate to get in touch with us via our website if you can help. #laboratory #tissueengineering #tissue pic.twitter.com/7TXNkE3SB8

1:00 am · October 25, 2021

CCRM_au

@CCRM_au

Welcome Sarmad Sonde to join CCRM Australia as an intern. Sarmad is excited "to learn more about our partners" and involve in the #commercialisation of #RegenerativeMedicine in his internship. pic.twitter.com/Rweu5u8NCE

1:00 am · October 22, 2021

CCRM_au

@CCRM_au

Learn more about CCRM Australia and Australia's regenerative medicine sector from @silvio12, CEO of @CCRM_au, in the @AusBiotech journal - Australasian Biotechnology. Read the journal online via nuvi.me/2drwuv #RegenerativeMedicine #regenmed #cellandgenetherapies pic.twitter.com/WxpowVXIgf

10:00 pm · October 21, 2021

CCRM_au

@CCRM_au

Thank you @TDM_Growth for joining the CCRM Australia International Regenerative Medicine SuperPitch IV panel. TDM aims to back Australian talent to address challenges impacting us, with #regenerativemedicine being one of the solutions. Learn more via tdmgrowthpartners.com pic.twitter.com/k8oxoSlDem

4:57 am · October 21, 2021

CCRM_au

@CCRM_au

CCRM Australia is attending #AusBio21 and is sponsoring a session on regulatory approaches in #regenerativemedicine. See you at the conference in a week! Visit nuvi.me/p6nt7s for more details. @AusBiotech pic.twitter.com/CbVE2GSB7m

12:00 am · October 19, 2021

Related Posts